Ozempic and Mounjaro are both once-weekly injections used to manage type 2 diabetes, and both are frequently discussed for their weight-loss effects. They work differently at the receptor level, though, which is why one is sometimes recommended over the other.
Active ingredient and mechanism
Ozempic contains semaglutide, a GLP-1 receptor agonist — it acts on a single hormone pathway to slow digestion and increase feelings of fullness. Mounjaro contains tirzepatide, which activates both the GIP and GLP-1 receptors. This dual mechanism is thought to be why tirzepatide has shown somewhat greater average weight loss than semaglutide in head-to-head trial data. See our full guide to how Mounjaro injections work for more detail.
Approved use
Ozempic is licensed for managing type 2 diabetes; any weight loss is a secondary effect of that mechanism, and it isn’t licensed specifically as a weight-loss treatment — Wegovy contains the same active ingredient at a dose licensed for chronic weight management. Mounjaro is licensed for type 2 diabetes, while its sister product Zepbound (same active ingredient, different brand) is licensed specifically for weight management.
Dosing
Both are titrated gradually to manage side effects. Ozempic typically starts at 0.25mg weekly, increasing to a maintenance dose of 1 or 2mg. Mounjaro follows its own gradual titration schedule — see our full Mounjaro dosing schedule for the week-by-week breakdown. Neither should be dose-adjusted without your prescriber’s guidance.
Side effects
Both share a similar gastrointestinal side-effect profile — nausea, diarrhoea, and constipation are the most commonly reported, usually easing as your body adjusts to each dose increase. See our Ozempic side effects guide and Mounjaro side effects guide for a full breakdown, and our GLP-1 drug interactions guide if you’re taking other medications.
Eligibility and how to order
Both are prescription-only. Eligibility is assessed through a short online questionnaire reviewed by our clinical team, and a prescription is issued only where clinically appropriate for you — see our full eligibility guide or start your Mounjaro assessment.
Which one is right for you?
If you have type 2 diabetes and haven’t tried a GLP-1 medication before, your prescriber may start with Ozempic. If you’re specifically focused on weight management, or haven’t seen the results you wanted from a single-pathway GLP-1 medication, Mounjaro’s dual mechanism may be discussed instead. This is a decision your prescriber will help you make based on your health history and goals.
Frequently Asked Questions
Is Mounjaro more effective than Ozempic for weight loss?
Mounjaro has shown somewhat greater average weight loss in head-to-head trial data, likely due to its dual GIP/GLP-1 mechanism, but individual response varies and your prescriber will advise based on your history.
Can I switch from Ozempic to Mounjaro?
Many people transition between GLP-1 medications under prescriber guidance — mention your current medication during your assessment so it can be reviewed.
Is Ozempic approved for weight loss?
Ozempic is licensed for type 2 diabetes management; Wegovy contains the same active ingredient at a dose specifically licensed for chronic weight management.
Do Ozempic and Mounjaro have the same side effects?
Both share a similar gastrointestinal side-effect profile, though individual tolerability can differ between the two.